Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atlas of Cerebrospinal Fluid Immune Cells Across Neurological Diseases.
Heming M, Börsch AL, Melnik S, Gmahl N, Müller-Miny L, Dambietz C, Fisch L, Kühnel T, Brix TJ, Janssen A, Schumann E, Gross CC, Varghese J, Hahn T, Wiendl H, Meyer Zu Hörste G. Heming M, et al. Among authors: muller miny l. Ann Neurol. 2024 Dec 12. doi: 10.1002/ana.27157. Online ahead of print. Ann Neurol. 2024. PMID: 39665159
Molekulare Biomarker bei neuroinflammatorischen Erkrankungen.
Müller-Miny L, Lünemann J. Müller-Miny L, et al. Fortschr Neurol Psychiatr. 2024 Nov;92(11):468-481. doi: 10.1055/a-2335-0149. Epub 2024 Nov 7. Fortschr Neurol Psychiatr. 2024. PMID: 39510124 German. No abstract available.
Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy.
Deffner M, Schneider-Hohendorf T, Schulte-Mecklenbeck A, Falk S, Lu IN, Ostkamp P, Müller-Miny L, Schumann EM, Goelz S, Cahir-McFarland E, Thakur KT, De Jager PL, Klotz L, Meyer Zu Hörste G, Gross CC, Wiendl H, Grauer OM, Schwab N. Deffner M, et al. Among authors: muller miny l. Cell Rep Med. 2024 Jul 16;5(7):101622. doi: 10.1016/j.xcrm.2024.101622. Epub 2024 Jun 24. Cell Rep Med. 2024. PMID: 38917802 Free PMC article.
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry.
Heming M, Müller-Miny L, Rolfes L, Schulte-Mecklenbeck A, Brix TJ, Varghese J, Pawlitzki M, Pavenstädt H, Kriegel MA, Gross CC, Wiendl H, Meyer Zu Hörste G. Heming M, et al. Among authors: muller miny l. J Neuroinflammation. 2023 Feb 23;20(1):46. doi: 10.1186/s12974-023-02733-w. J Neuroinflammation. 2023. PMID: 36823602 Free PMC article.
Letter to the editor regarding "Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials".
Schulte-Mecklenbeck A, Zinnhardt B, Müller-Miny L, Haessner S, Meyer Zu Hörste G, Wiendl H, Gross CC. Schulte-Mecklenbeck A, et al. Among authors: muller miny l. J Immunol Methods. 2023 Mar;514:113428. doi: 10.1016/j.jim.2023.113428. Epub 2023 Jan 20. J Immunol Methods. 2023. PMID: 36690066 No abstract available.
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Diaz-Manera J, et al. Lancet Neurol. 2021 Dec;20(12):1012-1026. doi: 10.1016/S1474-4422(21)00241-6. Lancet Neurol. 2021. PMID: 34800399 Clinical Trial.